Sign up Australia
Proactive Investors - Run By Investors For Investors

European Lithium settles sale of Western Australian gold project

The company is focusing on its Wolfsberg Lithium Project in Austria.
Hand shake
The total sale consideration amounts to $1 million

European Lithium Ltd (ASX:EUR) has settled the sale of its Paynes Find Gold Project in Western Australia to Cervantes Gold Pty Ltd (ASX:CVS).

Total consideration for the sale comprises $500,000 cash and $500,000 in share consideration through the issue of shares in CVS, at $0.02 each.

European Lithium has received $220,000 with two instalments of $25,000 to be paid on or before 15 January 2018 and 28 February 2018.

Final cash instalment due by end of March

The final instalment of $230,000 is to be paid by CVS on or before 31 March 2018.

The shares will be issued on or before 29 December 2017.

Tony Sage, chairman, commented:

"We are very pleased to settle the sale of the Paynes Find Gold project with CVS.

"The company’s focus remains on finalising the PFS at the company’s flagship Wolfsberg Lithium project as well as better understanding the size and value of the deposit in Zone 2."

View full EUR profile View Profile

European Lithium Ltd Timeline

Related Articles

Mawson Resources poised for more drilling after bonanza gold grades at Rompas East
October 19 2017
The group's key assets is the Rompas/Rajapalot project in Fiinish Lapland
picture of light bulbs
October 31 2017
The price of tungsten rose to a three-year high of over US$310 per metric tonne during the quarter
medgold_pic_596f7e563cd09.png
July 19 2017
Medgold has earmarked drilling to start at the Tlamino project in Serbia in August

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use